A Nation-wide, retrospective study of cohort of patients with venous thromboembolism treated with rivaroxaban or vitamin K antagonists.
Latest Information Update: 27 Mar 2017
At a glance
- Drugs Rivaroxaban (Primary) ; Vitamin K antagonists (Primary)
- Indications Venous thromboembolism
- Focus Adverse reactions
- 16 Mar 2017 Results (n=18416) published in the Thrombosis and Haemostasis
- 22 Nov 2016 New trial record